JPRN-UMIN000054168尚未招募Unknown
A nationwide retrospective study of malignant tumors arising from ovarian mature teratoma in Japan - JGOG3034
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Other
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •The individual or family member has clearly expressed a refusal to opt out. The researcher considers it inappropriate, citing difficulties in obtaining data.
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate long-term safety of nivolumab for subjects with cancer who will be provided nivolumab or have finished treatment and are now in or have completed follow up on another study of nivolumab or nivolumab combinatiopan tumorMedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000004864EUCTR2018-004362-34-PTBristol-Myers Squibb International Corporation1,231
进行中（未招募）
1 期
Study to evaluate long-term safety of nivolumab for subjects with cancer who will be provided nivolumab or have finished treatment and are now in or have completed follow up on another study of nivolumab or nivolumab combinatiopan tumorMedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000004864EUCTR2018-004362-34-ESBristol-Myers Squibb International Corporation1,231
进行中（未招募）
1 期
Study to evaluate long-term safety of nivolumab for subjects with cancer who will be provided nivolumab or have finished treatment and are now in or have completed follow up on another study of nivolumab or nivolumab combinatiopan tumorMedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000004864EUCTR2018-004362-34-NLBristol-Myers Squibb International Corporation1,231
进行中（未招募）
1 期
Study to evaluate long-term safety of nivolumab for subjects with cancer who will be provided nivolumab or have finished treatment and are now in or have completed follow up on another study of nivolumab or nivolumab combinatioEUCTR2018-004362-34-NOBristol-Myers Squibb International Corporation1,231
撤回
2 期
Pan Tumor Study for Long Term Follow-up of Cancer Survivors Who Have Participated in Trials Investigating NivolumabCancerNL-OMON50106Bristol-Myers Squibb10